Phase
Condition
Dystonias
Neurologic Disorders
Myasthenia Gravis (Chronic Weakness)
Treatment
N/AClinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
o neuromuscular disease ( progressive muscular dystrophy, for example; Duchennemuscular dystrophy, spinal muscular atrophy)
age ≥ 18 years
indication to NIV (ongoing ventilation or new patients)
vital capacity ≤ 50% pred
peak cough flow < 270 l/min
"LIAM Responder" = increased insufflation capacity (≥ + 50%) and Peak Cough Flow (PCF ≥+ 50%) with LIAM
Exclusion
Exclusion Criteria:
o acute respiratory failure (respiratory acidosis)
home treatment by instrumental cough assistance in the preceding 12 months
ongoing medical treatment of the neuromuscular disease (for ex: corticosteroidsin Duchenne disease, enzyme therapy in Pompe disease)
previous pneumothorax
plan of legal protection
pregnant or breastfeeding women
failure to cooperate
no affiliation to a social security scheme
Study Design
Study Description
Connect with a study center
Home ventilation Unit , Raymond Poincaré hospital
Garches, Paris Area 92380
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.